The association between metabolic syndrome and heart failure in middle-aged men and women: population-based study of 2 million individuals
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: Although an association is known to exist between metabolic syndrome (MetS) and heart failure (HF) risk, large longitudinal studies are limited. We investigated metabolic status as a risk factor for HF in middle-aged men and women and considered sex differences in various risk factors for HF using nationwide real-world data. METHODS: Data obtained from the Korean National Health Insurance Service from 2009 to 2016 were analyzed. A total of 2,151,597 middle-aged subjects (between 50 and 59 years old) were enrolled. Subjects were divided into 3 groups (normal, pre‐ MetS, and MetS). Cox proportional hazard models were used to estimate the association between MetS and incident HF after adjusting for clinical risk factors. RESULTS: At baseline, MetS existed in 23.77% of men and 10.58% of women. Pre-MetS and MetS increased the risk of HF: the hazard ratios of pre-MetS for incident HF were 1.508 (95% confidence interval [CI], 1.287 to 1.767) in men and 1.395 (95% CI, 1.158 to 1.681) in women, and those of MetS were 1.711 (95% CI, 1.433 to 2.044) in men and 2.144 (95% CI, 1.674 to 2.747) in women. Current smoking, a low hemoglobin level, underweight (body mass index < 18.5 kg/m2 ), a high creatinine level, and acute myocardial infarction were also predictors of HF in both sexes. CONCLUSIONS: Pre-MetS and MetS were identified as risk factors for HF in middle-aged men and women. The effect of MetS on the occurrence of HF was stronger in women than in men. Pre-MetS was also a predictor of HF, but was associated with a lower risk than MetS.
Abstract
OBJECTIVES: Although an association is known to exist between metabolic syndrome (MetS) and heart failure (HF) risk, large longitudinal studies are limited. We investigated metabolic status as a risk factor for HF in middle-aged men and women and considered sex differences in various risk factors for HF using nationwide real-world data. METHODS: Data obtained from the Korean National Health Insurance Service from 2009 to 2016 were analyzed. A total of 2,151,597 middle-aged subjects (between 50 and 59 years old) were enrolled. Subjects were divided into 3 groups (normal, pre‐ MetS, and MetS). Cox proportional hazard models were used to estimate the association between MetS and incident HF after adjusting for clinical risk factors. RESULTS: At baseline, MetS existed in 23.77% of men and 10.58% of women. Pre-MetS and MetS increased the risk of HF: the hazard ratios of pre-MetS for incident HF were 1.508 (95% confidence interval [CI], 1.287 to 1.767) in men and 1.395 (95% CI, 1.158 to 1.681) in women, and those of MetS were 1.711 (95% CI, 1.433 to 2.044) in men and 2.144 (95% CI, 1.674 to 2.747) in women. Current smoking, a low hemoglobin level, underweight (body mass index < 18.5 kg/m2 ), a high creatinine level, and acute myocardial infarction were also predictors of HF in both sexes. CONCLUSIONS: Pre-MetS and MetS were identified as risk factors for HF in middle-aged men and women. The effect of MetS on the occurrence of HF was stronger in women than in men. Pre-MetS was also a predictor of HF, but was associated with a lower risk than MetS.
참고문헌 (33)
- Bozkurt B, "Universal definition and classification of heart failure : a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure", J Card Fail, 27, pp.387~413 (2021)
- Braunwald E, "Heart failure", JACC Heart Fail, 1, pp.1~20 (2013)
- Askoxylakis V, "Long-term survival of cancer patients compared to heart failure and stroke : a systematic review", BMC Cancer, 10, pp.105~ (2010)
- Park JJ, "Heart failure statistics in Korea, 2020 : a report from the Korean Society of Heart Failure", Int J Heart Fail, 3, pp.224~236 (2021)
- Aguilar M, "Prevalence of the metabolic syndrome in the United States, 2003-2012", JAMA, 313, pp.1973~1974 (2015)
- Gao W, "Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk?", Int J Obes (Lond), 32, pp.757~762 (2008)
- Rochlani Y, "Metabolic syndrome : pathophysiology, management, and modulation by natural compounds", Ther Adv Cardiovasc Dis, 11, pp.215~225 (2017)
- Miura Y, "Prevalence and clinical implication of metabolic syndrome in chronic heart failure", Circ J, 74, pp.2612~2621 (2010)
- Li C, "Association of metabolic syndrome and insulin resistance with congestive heart failure : findings from the Third National Health and Nutrition Examination Survey", J Epidemiol Community Health, 61, pp.67~73 (2007)
- Tamariz L, "Metabolic syndrome increases mortality in heart failure", Clin Cardiol, 32, pp.327~331 (2009)
- Perrone-Filardi P, "Prognostic impact of metabolic syndrome in patients with chronic heart failure : data from GISSI-HF trial", Int J Cardiol, 178, pp.85~90 (2015)
- Koutroumpakis E, "Strategies of unloading the failing heart from metabolic stress", Am J Med, 133, pp.290~296 (2020)
- Ingelsson E, "Metabolic syndrome and risk for heart failure in middle-aged men", Heart, 92, pp.1409~1413 (2006)
- Bahrami H, "Novel metabolic risk factors for incident heart failure and their relationship with obesity : the MESA(Multi-Ethnic Study of Atherosclerosis)study", J Am Coll Cardiol, 51, pp.1775~1783 (2008)
- Butler J, "Metabolic syndrome and the risk of cardiovascular disease in older adults", J Am Coll Cardiol, 47, pp.1595~1602 (2006)
- Wang J, "The metabolic syndrome predicts incident congestive heart failure : a 20-year follow-up study of elderly Finns", Atherosclerosis, 210, pp.237~242 (2010)
- Ho JE, "Predictors of new-onset heart failure : differences in preserved versus reduced ejection fraction", Circ Heart Fail, 6, pp.279~286 (2013)
- Ho JE, "Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community", Eur Heart J, 33, pp.1734~1741 (2012)
- Regitz-Zagrosek V, "Sex and gender differences in heart failure", Int J Heart Fail, 2, pp.157~181 (2020)
- Simmonds SJ, "Cellular and molecular differences between HFpEF and HFrEF : a step ahead in an improved pathological understanding", Cells, 9, pp.242~ (2020)
- Sulo G, "Heart failure complicating acute myocardial infarction; burden and timing of occurrence : a nation-wide analysis including 86 771patients from the Cardiovascular Disease in Norway(CVDNOR)Project", J Am Heart Assoc, 5, pp.e002667~ (2016)
- He J, "Risk factors for congestive heart failure in US men and women : NHANES I epidemiologic follow-up study", Arch Intern Med, 161, pp.996~1002 (2001)
- Levy D, "The progression from hypertension to congestive heart failure", JAMA, 275, pp.1557~1562 (1996)
- Kenchaiah S, "Obesity and the risk of heart failure", N Engl J Med, 347, pp.305~313 (2002)
- Savji N, "The association of obesity and cardiometabolic traits with incident HFpEF and HFrEF", JACC Heart Fail, 6, pp.701~709 (2018)
- Eaton CB, "Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women", Circ Heart Fail, 9, pp.e002883~ (2016)
- Huffman MD, "Lifetime risk for heart failure among white and black Americans : cardiovascular lifetime risk pooling project", J Am Coll Cardiol, 61, pp.1510~1517 (2013)
- Björck L, "Body mass index in women aged 18 to 45 and subsequent risk of heart failure", Eur J Prev Cardiol, 27, pp.1165~1174 (2020)
- Rosengren A, "Body weight in adolescence and long-term risk of early heart failure in adulthood among men in Sweden", Eur Heart J, 38, pp.1926~1933 (2017)
- 이은정, "Associations among Obesity Degree, Glycemic Status, and Risk of Heart Failure in 9,720,220 Korean Adults", Diabetes and Metabolism Journal, 44(4), pp.592~601 (2020), 대한당뇨병학회[DOI]
- Varat MA, "Cardiovascular effects of anemia", Am Heart J, 83, pp.415~426 (1972)
- Klip IT, "Hemoglobin levels and new-onset heart failure in the community", Am Heart J, 169, pp.94~101 (2015)
- Coglianese EE, "Usefulness of the blood hematocrit level to predict development of heart failure in a community", Am J Cardiol, 109, pp.241~245 (2012)